What is the significance of the SLC6A2 gene in ADHD?

PostedAugust 18, 2025

UpdatedSeptember 3, 2025

ByMy Patient Advice

Author: Lucia Alvarez, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

The SLC6A2 gene, which encodes the norepinephrine transporter, plays a vital role in the brain’s attention and stress response systems. In the context of SLC6A2 gene ADHD, variations in this gene can impact how efficiently norepinephrine is cleared from the synapses, affecting alertness, focus, and emotional regulation. These disruptions have been linked to increased ADHD symptoms, especially those tied to inattention and hyperactivity.

Because norepinephrine is key to managing attention and arousal, the SLC6A2 gene is a focus of genetic and pharmacological ADHD research.

How SLC6A2 affects ADHD

Here’s what makes this gene important in understanding the condition.

Norepinephrine transporter

The norepinephrine transporter, influenced by the SLC6A2 gene, regulates how much of this brain chemical remains active. Abnormalities in this transporter can lead to heightened distractibility or restlessness, as the brain struggles to maintain steady levels of stimulation.

ADHD mutation

Although not always classified as a mutation in the traditional sense, certain gene variants in SLC6A2 have been identified in people with ADHD. These ADHD mutations can alter transporter function, contributing to the neurobiological underpinnings of the condition.

Recognising the role of the SLC6A2 gene in ADHD helps clinicians understand why non-stimulant medications targeting norepinephrine systems may benefit certain individuals. Visit providers like ADHD Certify to learn more about genetic testing and tailored therapy plans.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic Factors in ADHD.

Lucia Alvarez, MSc

Author

Lucia Alvarez is a clinical psychologist with a Master’s in Clinical Psychology and extensive experience providing evidence-based therapy and psychological assessment to children, adolescents, and adults. Skilled in CBT, DBT, and other therapeutic interventions, she has worked in hospital, community, and residential care settings. Her expertise includes grief counseling, anxiety management, and resilience-building, with a strong focus on creating safe, supportive environments to improve mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.